Results 161 to 170 of about 411,617 (199)

Insulin degludec

Reactions Weekly, 2019
openaire   +1 more source

Insulin/insulin-aspart/insulin-degludec

Reactions Weekly, 2020
openaire   +1 more source

Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)

Diabetes Care, 2012
Bernard Zinman, Bertrand Cariou, Athena Philis-Tsimikas   +2 more
exaly  

One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial

Diabetes, Obesity and Metabolism, 2015
John Buse, S C L Gough
exaly  

Insulin-degludec overdose

Reactions Weekly, 2022
openaire   +1 more source

Clinical relevance of pharmacokinetic and pharmacodynamic profiles of insulin degludec (100, 200 U/mL) and insulin glargine (100, 300 U/mL) – a review of evidence and clinical interpretation

Diabetes and Metabolism, 2019
David R Owens, Carmine Giuseppe Fanelli, Geremia B Bolli   +2 more
exaly  

Insulin degludec/liraglutide

Reactions Weekly, 2023
openaire   +1 more source

Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine

Expert Opinion on Drug Metabolism and Toxicology, 2015
Tim Heise, Leszek Nosek, Hanne Haahr
exaly  

Insulin degludec: a new ultra-longacting insulin

The Lancet, 2012
Abd A, Tahrani, Clifford J, Bailey, Anthony H, Barnett   +2 more
openaire   +2 more sources

Insulin-degludec/metformin

Reactions Weekly, 2021
openaire   +1 more source